Product Images Promethazine Hci
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Promethazine Hci NDC 51662-1247 by Hf Acquisition Co. Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
The text is a label of a medication named Promethazine HC! Injection, with NDC number 0641-0928-21. The medication is in a 1mL vial and is recommended to be administered by Deep IM or IV use. It should be protected from light and stored properly.*
PROMETHAZINE HCI INJECTION, USP 25mg/mL 1mL is a medication for deep intramuscular or intravenous use. Its usual dosage is available in the package insert. It is recommended to keep it covered in the carton to protect it from light. The recommended storage temperature is 20°C-25°C (68°-77°F). The manufacturer’s package insert provides additional information. The medication is manufactured by HF Acquisition Co., LLC, located in Mukilteo, WA. The information includes NDC (51662-1247-2), LOT, EXP, and RXONLY.*
PROMETHAZINE HCI INJECTION, USP 25mg/mL 1mL is a prescription drug used for deep intramuscular or intravenous use. It has an NDC code of 51662-1247-3, LOT number of 12345, and an expiration date of 2030-01-01. The usual dosage must be confirmed by checking the package insert. It should be kept protected from light and stored at a controlled room temperature. The manufacturer's package insert should be referred. It is manufactured by HF Acquisition Co., LLC with an original NDC code of 0641-0928-25.*
This is a warning that Promethazine hydrochloride injection is not safe for use in children under 2 years of age due to the risk of fatal respiratory depression. It can cause severe chemical irritation and tissue damage, leading to burning, pain, thrombophlebitis, tissue necrosis, and gangrene. Intramuscular injection is preferred over intravenous injection, and subcutaneous injection is not recommended. This text provides important information on administration and warnings for this medication.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.